ESTRO 2023 - Abstract Book

TUESDAY 16 MAY 2023

Teaching Lecture Statistical methods and analysis for large datasets.............................................................................................. (abs. 0985) Paediatric radiotherapy - What is state-of-the-art?..................................................................................... (abs. 0986-0987) Optimal treatment of bladder cancer in the elderly and frail populations........................................................ (abs. 0988) Secondary malignancies from radiation - Is the prophecy fulfilled?................................................................... (abs. 0989) Status and recent developments in PET for adaptive radiotherapy. .................................................................. (abs. 0990) MRI-only radiotherapy: Principles, challenges and future prospects. ................................................................ (abs. 0991) Living with, and beyond, cancer.............................................................................................................................. (abs. 0992) Symposium Guidelines. ...................................................................................................................................................... (abs. 0993-1000) Back to the future - The automated radiation oncology workflow in 2030.............................................. (abs. 1001-1004) Debate Radiotherapy and oligometastatic prostate cancer - This house believes we are ready for a new treatment paradigm............................................................................................................................ (abs. 1005-1010) of gynaecological cancers.............................................................................................................................. (abs. 1011-1013) Reducing the target volumes in external beam therapy............................................................................ (abs. 1014-1016) Proton arc therapy: Status and potential..................................................................................................... (abs. 1017-1020) Advances in communication technologies within radiotherapy................................................................ (abs. 1021-1023) Debate This house believes that tumour-specific radiosensitisation is an unachievable radiobiological fantasy................................................................................................................................... (abs. 1024-1029) Symposium Shared decision-making in radiotherapy..................................................................................................... (abs. 1030-1032) to the metastatic setting................................................................................................................................ (abs. 1033-1035) ESTRO-ESGO-ESP: Guidelines on cervical cancer........................................................................................ (abs. 1036-1041) Symposium What’s new in particle therapy?.................................................................................................................... (abs. 1042-1045) Handling longitudinal imaging data. ............................................................................................................ (abs. 1046-1049) Use of virtual reality in radiotherapy............................................................................................................ (abs. 1050-1052) Symposium How to introduce innovations in risk stratification to clinical management Joint Symposium ESTRO-RANZCR: Role of radiotherapy in renal cell carcinoma: From the primary